These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 32460897)

  • 21. Liquid biopsies: Potential and challenges.
    Heidrich I; Ačkar L; Mossahebi Mohammadi P; Pantel K
    Int J Cancer; 2021 Feb; 148(3):528-545. PubMed ID: 32683679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity and tumor evolution reflected in liquid biopsy in metastatic breast cancer patients: a review.
    Kavan S; Kruse TA; Vogsen M; Hildebrandt MG; Thomassen M
    Cancer Metastasis Rev; 2022 Jun; 41(2):433-446. PubMed ID: 35286542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of liquid biopsies in colorectal cancer.
    Wills B; Gorse E; Lee V
    Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA.
    Giannopoulou L; Kasimir-Bauer S; Lianidou ES
    Clin Chem Lab Med; 2018 Jan; 56(2):186-197. PubMed ID: 28753534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development, Validation, and Regulatory Considerations for a Liquid Biopsy Test.
    Tsui DWY; Blumenthal GM; Philip R; Barrett JC; Montagut C; Bramlett K; Ladanyi M; Ghosh S
    Clin Chem; 2020 Mar; 66(3):408-414. PubMed ID: 32091082
    [No Abstract]   [Full Text] [Related]  

  • 26. Liquid biopsy in CNS tumors: Current status & future perspectives.
    Husain N; Husain A; Mishra S; Srivastava P
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond Standard Practice in Liquid Biopsy: Selective Venous Sampling.
    Damascelli B; Tichà V; Repetti E; Dorji T
    J Vasc Interv Radiol; 2021 May; 32(5):668-671. PubMed ID: 33621662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review.
    Chen X; Wang L; Lou J
    Med Sci Monit; 2020 Mar; 26():e921040. PubMed ID: 32200389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liquid Biopsy: A New Tool in Oncology.
    Costa JL; Schmitt FC
    Acta Cytol; 2019; 63(6):448. PubMed ID: 31266005
    [No Abstract]   [Full Text] [Related]  

  • 30. Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors.
    Pinzani P; D'Argenio V; Del Re M; Pellegrini C; Cucchiara F; Salvianti F; Galbiati S
    Clin Chem Lab Med; 2021 Jun; 59(7):1181-1200. PubMed ID: 33544478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers.
    Zhang Z; Wu H; Chong W; Shang L; Jing C; Li L
    Cell Death Dis; 2022 Oct; 13(10):903. PubMed ID: 36302755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Liquid biopsy to indvidualise therapy in advanced bladder cancer].
    Junker K
    Aktuelle Urol; 2022 Apr; 53(2):180-187. PubMed ID: 34875700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA.
    Onidani K; Shoji H; Kakizaki T; Yoshimoto S; Okaya S; Miura N; Sekikawa S; Furuta K; Lim CT; Shibahara T; Boku N; Kato K; Honda K
    Cancer Sci; 2019 Aug; 110(8):2590-2599. PubMed ID: 31169336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors.
    Reduzzi C; Nicolo' E; Singhal S; Venetis K; Ortega-Franco A; de Miguel-Perez D; Dipasquale A; Gouda MA; Saldanha EF; Kasi PM; Jantus-Lewintre E; Fusco N; Malapelle U; Gandara DR; Rolfo C; Serrano MJ; Cristofanilli M;
    Crit Rev Oncol Hematol; 2024 Nov; 203():104483. PubMed ID: 39159706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods for the Detection of Circulating Biomarkers in Cancer Patients.
    Mondelo-Macía P; Rodríguez-Ces AM; Suárez-Cunqueiro MM; Romay LM
    Adv Exp Med Biol; 2022; 1379():525-552. PubMed ID: 35761006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of liquid biopsy in the management of cancer patients.
    Markou A; Tzanikou E; Lianidou E
    Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid Biopsy in Bladder Cancer.
    Cui Y; Cao M
    Methods Mol Biol; 2023; 2695():111-120. PubMed ID: 37450114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Different Facets of Liquid Biopsy: A Kaleidoscopic View.
    Eslami-S Z; Cortés-Hernández LE; Cayrefourcq L; Alix-Panabières C
    Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and future perspectives of liquid biopsies in genomics-driven oncology.
    Heitzer E; Haque IS; Roberts CES; Speicher MR
    Nat Rev Genet; 2019 Feb; 20(2):71-88. PubMed ID: 30410101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
    Ray SK; Mukherjee S
    Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.